e-learning
resources
Conferences
6th Sleep and Breathing Conference, Online 2021
2021
16.04.2021
Treatment and management of sleep respiratory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Variability of OSA severity measures on repeated testing.
M. Meszaros (Zurich, Switzerland), M. Nido (Zurich, Switzerland), C. Issler (Zurich, Switzerland), J. Steier (London, United Kingdom), E. Schwarz (London, United Kingdom)
Source:
Sleep and Breathing Conference 2021
Session:
Treatment and management of sleep respiratory diseases
Session type:
Oral Presentation
Number:
0
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Meszaros (Zurich, Switzerland), M. Nido (Zurich, Switzerland), C. Issler (Zurich, Switzerland), J. Steier (London, United Kingdom), E. Schwarz (London, United Kingdom). Variability of OSA severity measures on repeated testing.. Sleep and Breathing Conference 2021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Related content which might interest you:
Variability of OSA severity classification between two multiple-night sleep studies
Source: Virtual Congress 2020 – Screening methods and diagnostic tools for obstructive sleep apnoea
Year: 2020
Effect of disease severity on heart rate recovery following laboratory and field exercise testing in patients with obstructive sleep apnea (OSA): A comparative study
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011
Comparison of two biomarkers to assess severity of pediatric sleep disordered breathing
Source: International Congress 2017 – Assessing the impact of respiratory and sleep problems in children
Year: 2017
24-h Holter monitoring in COPD. Correlations with clinical type, severity of disease and comorbidities
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007
Clinical relevance of constant power exercise duration changes in COPD
Source: Eur Respir J 2009; 33: 340-345
Year: 2009
Comparison of epworth sleepiness scale scores in patients with sleep apnea and their bedpartner's and its relationship with polysomnographic variables
Source: Eur Respir J 2003; 22: Suppl. 45, 272s
Year: 2003
Correlations between two instruments measuring sleep quality in patients with ILD: Preliminary results
Source: International Congress 2018 – Chronic respiratory disease : determinants of physical activity in patients
Year: 2018
Exercise testing in patients with COPD. VO2 measure in different tests
Source: Eur Respir J 2002; 20: Suppl. 38, 286s
Year: 2002
Responsiveness of 3 subjective instruments for assessment of functional status in patients with COPD
Source: Annual Congress 2008 - Respiratory mechanics, muscles and breathing; functional status measures and coping styles
Year: 2008
Efficiency of different multidimensional indexes for the assessment of the risk of exacerbations in patients with COPD
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020
Effect of treatment on morning symptoms in COPD. Correlation between doctors and patients in the evaluation of symptoms. SINCON Study
Source: International Congress 2018 – Patient-reported outcomes and scores in COPD
Year: 2018
Comparison of different criteria for the diagnosis of position and REM related obstructive sleep apnea syndrome and the value for determination of prognosis
Source: International Congress 2016 – Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders
Year: 2016
Association between patient-reported outcomes and exercise test outcomes in patients with COPD.
Source: Virtual Congress 2020 – New insights into determinants of patient-reported outcomes in chronic respiratory diseases
Year: 2020
Correlation between indices of quality of life and degree of severity of symptoms in patients with asthma in combination with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 520s
Year: 2004
Daytime physical activity and sleep quality as related to patient-reported and physiological outcomes following severe COPD exacerbation
Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases
Year: 2021
Functional tests during estimation of arterial stiffness in asthma patients
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008
The underestimated subjectivity of the COPD assessment test
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020
Baseline determinants of 1-minute sit-to-stand test performance in COPD patients
Source: International Congress 2015 – Latest insights into chronic care
Year: 2015
Detection of acute health status deterioration among COPD patients by monitoring COPD assessment test score
Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Year: 2011
Lack of agreement between the exercise variables to assess the risk in PAH.
Source: Virtual Congress 2021 – All about pulmonary arterial hypertension
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept